134 related articles for article (PubMed ID: 3813188)
21. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
Cheng D; Chen W; Jiang J
Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
[TBL] [Abstract][Full Text] [Related]
22. Use of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantation.
Gómez-Moreno S; Lage E; Hernández A; Campos A; Cabezón S; Ordóñez A; Hinojosa R
Transplant Proc; 2005 Apr; 37(3):1550-1. PubMed ID: 15866670
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
Mahowald ML; Weir EK; Ridley DJ; Messner RP
J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
[TBL] [Abstract][Full Text] [Related]
24. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
Hermiller JB; Bambach D; Thompson MJ; Huss P; Fontana ME; Magorien RD; Unverferth DV; Leier CV
Ann Intern Med; 1982 Oct; 97(4):480-9. PubMed ID: 7125407
[TBL] [Abstract][Full Text] [Related]
25. [Vasodilators, modern therapeutic approach in pulmonary arterial hypertension].
Gherasim L; Bogdan M
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(2):97-102. PubMed ID: 6127777
[No Abstract] [Full Text] [Related]
26. [Pharmacology of the pulmonary circulation].
Follath F
Schweiz Med Wochenschr; 1985 Sep; 115(39):1328-32. PubMed ID: 2866581
[TBL] [Abstract][Full Text] [Related]
27. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
Rosengarten B; Schermuly RT; Voswinckel R; Kohstall MG; Olschewski H; Weissmann N; Seeger W; Kaps M; Grimminger F; Ghofrani HA
Cerebrovasc Dis; 2006; 21(3):194-200. PubMed ID: 16388195
[TBL] [Abstract][Full Text] [Related]
28. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Dal Nogare AR; Rubin LJ
Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247
[TBL] [Abstract][Full Text] [Related]
29. [Antiserotonin action of several pharmacological substances on the vessels of the lungs and bronchi].
Zaslavskaia RM
Kardiologiia; 1969 Jun; 9(6):107-11. PubMed ID: 4389996
[No Abstract] [Full Text] [Related]
30. Prostaglandins and pulmonary hypertension-further evidence.
Das UN
Med Hypotheses; 1981 May; 7(5):621-4. PubMed ID: 7278727
[TBL] [Abstract][Full Text] [Related]
31. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
32. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.
Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL
J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396
[TBL] [Abstract][Full Text] [Related]
33. Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension.
Eysmann SB; Palevsky HI; Reichek N; Hackney K; Douglas PS
Chest; 1991 May; 99(5):1066-71. PubMed ID: 2019158
[TBL] [Abstract][Full Text] [Related]
34. [Basic principles of the current treatment of primary pulmonary hypertension].
Konopleva LF; Revutskiĭ EL; Previr VN
Kardiologiia; 1984 Oct; 24(10):121-5. PubMed ID: 6394865
[No Abstract] [Full Text] [Related]
35. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
36. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.
McGoon MD; Seward JB; Vlietstra RE; Choo MH; Moyer TP; Reeder GS
Br Heart J; 1983 Dec; 50(6):579-85. PubMed ID: 6652000
[TBL] [Abstract][Full Text] [Related]
37. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
38. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure.
Maruszewski M; Zakliczyński M; Przybylski R; Kucewicz-Czech E; Zembala M
Transplant Proc; 2007 Nov; 39(9):2850-2. PubMed ID: 18021999
[TBL] [Abstract][Full Text] [Related]
39. Anesthetic management of children with pulmonary arterial hypertension.
Galante D; Meola S; Pellico G; Tancredi ML; Milillo R
Paediatr Anaesth; 2008 Jun; 18(6):562-3; author reply 563-4. PubMed ID: 18445205
[No Abstract] [Full Text] [Related]
40. Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study.
Jing ZC; Yu ZX; Shen JY; Wu BX; Xu KF; Zhu XY; Pan L; Zhang ZL; Liu XQ; Zhang YS; Jiang X; Galiè N;
Am J Respir Crit Care Med; 2011 Jun; 183(12):1723-9. PubMed ID: 21471085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
